In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease

BACKGROUND: Lyme disease accounts for >90% of all vector-borne disease cases in the United States and affect ~300,000 persons annually in North America. Though traditional tetracycline antibiotic therapy is generally prescribed for Lyme disease, still 10%–20% of patients treated with current anti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Des Devel Ther
Autors principals: Pothineni, Venkata Raveendra, Parekh, Mansi B, Babar, Mustafeez Mujtaba, Ambati, Aditya, Maguire, Peter, Inayathullah, Mohammed, Kim, Kwang-Min, Tayebi, Lobat, Potula, Hari-Hara SK, Rajadas, Jayakumar
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6141111/
https://ncbi.nlm.nih.gov/pubmed/30254421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S164966
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars